• Je něco špatně v tomto záznamu ?

European Medical Education Initiative on Noonan syndrome: A clinical practice survey assessing the diagnosis and clinical management of individuals with Noonan syndrome across Europe

S. García-Miñaúr, E. Burkitt-Wright, A. Verloes, G. Shaikh, J. Lebl, I. Östman-Smith, CM. Wolf, E. Ortega Castelló, M. Tartaglia, M. Zenker, T. Edouard

. 2022 ; 65 (1) : 104371. [pub] 20211029

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22011464

INTRODUCTION: Noonan syndrome (NS) is a rare genetic disorder caused by mutations in genes encoding components of the RAS/mitogen-activated protein kinase (MAPK) signalling pathway. Patients with NS exhibit certain characteristic features, including cardiac defects, short stature, distinctive facial appearance, skeletal abnormalities, cognitive deficits, and predisposition to certain cancers. Here, a clinical practice survey was developed to learn more about differences in the diagnosis and management of this disease across Europe. The aim was to identify gaps in the knowledge and management of this rare disorder. MATERIALS AND METHODS: The European Medical Education Initiative on NS, which comprised a group of 10 experts, developed a 60-question clinical practice survey to gather information from European physicians on the diagnosis and clinical management of patients with diseases in the NS phenotypic spectrum. Physicians from three specialities (clinical genetics, paediatric endocrinology, paediatric cardiology) were invited to complete the survey by several national and European societies. Differences in answers provided by respondents between specialities and countries were analysed using contingency tables and the Chi-Squared test for independence. The Friedman's test was used for related samples. RESULTS: Data were analysed from 364 respondents from 20 European countries. Most respondents came from France (21%), Spain (18%), Germany (16%), Italy (15%), United Kingdom (8%) and the Czech Republic (6%). Respondents were distributed evenly across three specialities: clinical genetics (30%), paediatric endocrinology (40%) and paediatric cardiology (30%). Care practices were generally aligned across the countries participating in the survey. Delayed diagnosis did not emerge as a critical issue, but certain unmet needs were identified, including transition of young patients to adult medical services and awareness of family support groups. CONCLUSION: Data collected from this survey provide a comprehensive summary of the diagnosis and clinical management practices for patients with NS across different European countries.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011464
003      
CZ-PrNML
005      
20220506130800.0
007      
ta
008      
220425s2022 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejmg.2021.104371 $2 doi
035    __
$a (PubMed)34757053
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a García-Miñaúr, Sixto $u Institute of Medical and Molecular Genetics (INGEMM), Hospital Universitario La Paz Research Institute (IdiPAZ), Hospital Universitario La Paz, Madrid, Spain. Electronic address: sixto.garcia@salud.madrid.org
245    10
$a European Medical Education Initiative on Noonan syndrome: A clinical practice survey assessing the diagnosis and clinical management of individuals with Noonan syndrome across Europe / $c S. García-Miñaúr, E. Burkitt-Wright, A. Verloes, G. Shaikh, J. Lebl, I. Östman-Smith, CM. Wolf, E. Ortega Castelló, M. Tartaglia, M. Zenker, T. Edouard
520    9_
$a INTRODUCTION: Noonan syndrome (NS) is a rare genetic disorder caused by mutations in genes encoding components of the RAS/mitogen-activated protein kinase (MAPK) signalling pathway. Patients with NS exhibit certain characteristic features, including cardiac defects, short stature, distinctive facial appearance, skeletal abnormalities, cognitive deficits, and predisposition to certain cancers. Here, a clinical practice survey was developed to learn more about differences in the diagnosis and management of this disease across Europe. The aim was to identify gaps in the knowledge and management of this rare disorder. MATERIALS AND METHODS: The European Medical Education Initiative on NS, which comprised a group of 10 experts, developed a 60-question clinical practice survey to gather information from European physicians on the diagnosis and clinical management of patients with diseases in the NS phenotypic spectrum. Physicians from three specialities (clinical genetics, paediatric endocrinology, paediatric cardiology) were invited to complete the survey by several national and European societies. Differences in answers provided by respondents between specialities and countries were analysed using contingency tables and the Chi-Squared test for independence. The Friedman's test was used for related samples. RESULTS: Data were analysed from 364 respondents from 20 European countries. Most respondents came from France (21%), Spain (18%), Germany (16%), Italy (15%), United Kingdom (8%) and the Czech Republic (6%). Respondents were distributed evenly across three specialities: clinical genetics (30%), paediatric endocrinology (40%) and paediatric cardiology (30%). Care practices were generally aligned across the countries participating in the survey. Delayed diagnosis did not emerge as a critical issue, but certain unmet needs were identified, including transition of young patients to adult medical services and awareness of family support groups. CONCLUSION: Data collected from this survey provide a comprehensive summary of the diagnosis and clinical management practices for patients with NS across different European countries.
650    _2
$a genetické testování $7 D005820
650    _2
$a lidé $7 D006801
650    _2
$a Noonanové syndrom $x diagnóza $x genetika $x terapie $7 D009634
650    12
$a lékařská praxe - způsoby provádění $7 D010818
650    _2
$a průzkumy a dotazníky $7 D011795
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Burkitt-Wright, Emma $u Manchester Centre for Genomic Medicine, Manchester University NHS Foundation Trust and University of Manchester, Manchester, UK
700    1_
$a Verloes, Alain $u Department of Genetics, APHP-Robert Debré University Hospital and Université de Paris Medical School, Paris, France
700    1_
$a Shaikh, Guftar $u Department of Paediatric Endocrinology, Royal Hospital for Children, Glasgow, United Kingdom
700    1_
$a Lebl, Jan $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
700    1_
$a Östman-Smith, Ingegerd $u Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden
700    1_
$a Wolf, Cordula M $u Department of Congenital Heart Defects and Pediatric Cardiology, German Heart Center Munich, Technical University of Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
700    1_
$a Ortega Castelló, Eduardo $u Department of Statistics and Data Science, Faculty of Statistical Studies, Complutense University of Madrid, Madrid, Spain
700    1_
$a Tartaglia, Marco $u Genetics and Rare Diseases Research Division, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy
700    1_
$a Zenker, Martin $u Institute of Human Genetics, University Hospital Magdeburg, Magdeburg, Germany
700    1_
$a Edouard, Thomas $u Endocrine, Bone Diseases, and Genetics Unit, Children's Hospital, Toulouse University Hospital, RESTORE INSERM UMR1301, Toulouse, France
773    0_
$w MED00166495 $t European journal of medical genetics $x 1878-0849 $g Roč. 65, č. 1 (2022), s. 104371
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34757053 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130752 $b ABA008
999    __
$a ok $b bmc $g 1789188 $s 1162662
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 65 $c 1 $d 104371 $e 20211029 $i 1878-0849 $m European journal of medical genetics $n Eur. J. med. genet. $x MED00166495
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace